Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 45.34B | 50.39B | 43.73B | 67.17B | 67.94B | 61.95B |
Gross Profit | 16.88B | 18.52B | 15.36B | 14.44B | 16.66B | 13.69B |
EBITDA | 11.37B | 12.94B | 10.97B | 7.65B | 11.33B | 8.63B |
Net Income | 5.59B | 6.76B | 6.02B | 4.26B | 6.50B | 4.42B |
Balance Sheet | ||||||
Total Assets | 127.64B | 125.90B | 123.80B | 101.42B | 97.28B | 82.30B |
Cash, Cash Equivalents and Short-Term Investments | 29.60B | 27.68B | 46.15B | 27.60B | 35.94B | 31.00B |
Total Debt | 83.25B | 75.33B | 78.25B | 59.06B | 53.77B | 48.64B |
Total Liabilities | 96.23B | 92.50B | 92.40B | 73.87B | 71.95B | 61.94B |
Stockholders Equity | 31.23B | 33.23B | 31.39B | 27.54B | 25.32B | 20.34B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -6.55B | 3.42B | -10.36B | 1.73B | 541.00M |
Operating Cash Flow | 0.00 | 495.00M | 7.34B | -4.86B | 5.13B | 1.33B |
Investing Cash Flow | 0.00 | -10.42B | -5.38B | -4.67B | -4.04B | -669.00M |
Financing Cash Flow | 0.00 | -8.56B | 16.55B | 2.91B | 3.31B | -3.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | ¥77.97B | 15.42 | 3.39% | -9.53% | -10.29% | ||
66 Neutral | $17.24B | 17.99 | 5.60% | 3.67% | 6.63% | 11.55% | |
― | $371.84M | 9.57 | 5.05% | 1.39% | ― | ― | |
― | $551.48M | 14.35 | 3.54% | ― | ― | ― | |
71 Outperform | ¥9.48B | 13.17 | 1.86% | 0.72% | 153.87% | ||
55 Neutral | ¥57.66B | 156.89 | 1.49% | -21.43% | ― | ||
48 Neutral | ¥26.34B | 129.28 | 2.07% | 19.71% | -82.80% |